GT Medical Technologies
Tempe, US · Founded 2017 · Delaware corporation · 7 known investors
GammaTile Therapy, a surgically targeted radiation therapy for operable brain tumors
Healthtech
Founders & leadership
PL
Per LangoeExecutive Officer, Director
DG
David G. BrachmanExecutive Officer, Director
GP
Geoff PardoDirector
PL
Prattipati LaxminarainDirector
KD
Kyle DempseyDirector
CR
Camilo RicoDirector
AL
Adam LesslerDirector
SA
Susana AmorimDirector
JR
Jason RostovskyDirector
PE
Paul EneverDirector
JL
James LeechExecutive Officer
RC
Radu CautisDirector
Investors · 7
FemHealth VenturesShort Hills
Evidity Health CapitalreportedNew York · $5M
Gilde HealthcarereportedUtrecht · $1.1M – $55M
Medical Technology Venture PartnersreportedSan Francisco
MedTech Venture PartnersreportedScottsdale
MVM Life Science PartnersreportedLondon · $20M – $100M
Viking Global Investorsreported
Reported raises · per SEC filings
Form D private placements▶$50.1MraisedJul 2026 · 39 investors · Other Health CareRule 506(b)
▶$50.1MraisedJul 2026 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
- David BrachmanExecutive Officer, Director
- Per LangoeExecutive Officer, Director
- Prattipati LaxminarainExecutive Officer, Director
- Kyle DempseyDirector
- Susana AmorimDirector
- Jason RostovskyDirector
- Paul EneverDirector
- James LeechExecutive Officer
- Offering amount
- $100.1M
- Amount sold
- $50.1M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$53.3MraisedJun 2025 · 37 investors · Other Health CareRule 506(b)
▶$53.3MraisedJun 2025 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Per LangoeExecutive Officer, Director
- David G. BrachmanExecutive Officer, Director
- Geoff PardoDirector
- Prattipati LaxminarainDirector
- Kyle DempseyDirector
- Camilo RicoDirector
- Adam LesslerDirector
- Offering amount
- $53.3M
- Amount sold
- $53.3M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$218KraisedApr 2024 · 1 investors · Other Health CareRule 506(b)
▶$218KraisedApr 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Per LangoeExecutive Officer, Director
- Radu CautisDirector
- Geoff PardoDirector
- Prattipati LaxminarainDirector
- David G. BrachmanExecutive Officer, Director
- Kyle DempseyDirector
- Offering amount
- $218K
- Amount sold
- $218K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.4MraisedMar 2023 · 33 investors · Other Health CareRule 506(b)
▶$37.4MraisedMar 2023 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David G. BrachmanExecutive Officer, Director
- Kyle DempseyDirector
- Radu CautisDirector
- Prattipati LaxminarainDirector
- Matthew E. LikensExecutive Officer, Director
- Geoff PardoDirector
- Offering amount
- $45.1M
- Amount sold
- $37.4M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.5MraisedNov 2020 · 15 investors · Other Health CareRule 506(b)
▶$15.5MraisedNov 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Prattipati LaxminarainDirector
- Matthew E. LikensExecutive Officer, Director
- Kyle DempseyDirector
- Radu CautisDirector
- David G. BrachmanExecutive Officer, Director
- Brian MartinExecutive Officer
- Offering amount
- $16M
- Amount sold
- $15.5M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.6MraisedNov 2018 · 30 investors · Other Health CareRule 506(b)
▶$5.6MraisedNov 2018 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- PRATTIPATI LAXMINARAINDirector
- Matthew E. LikensExecutive Officer, Director
- David G. BrachmanDirector
- Radu CautisDirector
- Offering amount
- $10M
- Amount sold
- $5.6M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.9MraisedJan 2018 · 4 investors · Other Health CareRule 506(b)
▶$1.9MraisedJan 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Heyoung McBridePromoter
- Emad YoussefPromoter
- David G. BrachmanExecutive Officer, Director, Promoter
- Radu CautisDirector
- Theresa A. ThomasPromoter
- Peter NakajiPromoter
- Matthew E. LikensExecutive Officer, Director
- Partners I, LP Medical Technology VenturePromoter
- Offering amount
- $2.2M
- Amount sold
- $1.9M
- Minimum investment
- $1.4M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$510KraisedDec 2017 · 5 investors · Other Health CareRule 506(b)
▶$510KraisedDec 2017 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew E. LikensExecutive Officer, Director
- Emad YoussefDirector, Promoter
- Peter NakajiDirector
- Theresa A. ThomasDirector, Promoter
- David G. BrachmanExecutive Officer, Director, Promoter
- Heyoung McBrideDirector
- Offering amount
- $750K
- Amount sold
- $510K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- GT Medical Technologies has raised $100 Million in new Series E funding - intelligence360intelligence360.news · 2026
- GT Medical Technologies closes $100M series E round - Phoenix Business Journalbizjournals.com · 2026
- GT Medical raises $100M for brain tumor tech after clinical trial success | MedTech Divemedtechdive.com · 2026
- GT Medical Technologies Completes Oversubscribed $100 Million Series E Equity Financing to Advance Commercial Treatment for Patients with Operable Brain Tumorsprnewswire.com · 2026